$36,000 of DANAHER CORPORATION lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues pertaining to the regulation of cell and gene therapy products. Issues pertaining to the biomedical research enterprise."
You can find more data on corporate lobbying on Quiver Quantitative.
DHR Insider Trading Activity
DHR insiders have traded $DHR stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $DHR stock by insiders over the last 6 months:
- GREGORY M MILOSEVICH (Executive Vice President) sold 1,320 shares for an estimated $274,574
- ALAN G SPOON sold 1,358 shares for an estimated $237,206
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
DHR Hedge Fund Activity
We have seen 821 institutional investors add shares of DHR stock to their portfolio, and 1,127 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS added 8,322,198 shares (+1445.9%) to their portfolio in Q1 2026, for an estimated $1,556,583,913
- CAPITAL INTERNATIONAL INVESTORS removed 4,231,295 shares (-23.2%) from their portfolio in Q1 2026, for an estimated $791,421,416
- HOLOCENE ADVISORS, LP added 3,099,516 shares (+329.9%) to their portfolio in Q1 2026, for an estimated $579,733,472
- FMR LLC added 3,027,600 shares (+15.5%) to their portfolio in Q1 2026, for an estimated $566,282,304
- BESSEMER GROUP INC removed 2,060,465 shares (-98.3%) from their portfolio in Q1 2026, for an estimated $385,389,373
- AGF MANAGEMENT LTD removed 1,958,435 shares (-99.8%) from their portfolio in Q1 2026, for an estimated $366,305,682
- MILLENNIUM MANAGEMENT LLC removed 1,863,602 shares (-91.1%) from their portfolio in Q1 2026, for an estimated $348,568,118
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
DHR Analyst Ratings
Wall Street analysts have issued reports on $DHR in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 01/29/2026
- Jefferies issued a "Buy" rating on 01/29/2026
To track analyst ratings and price targets for DHR, check out Quiver Quantitative's $DHR forecast page.
DHR Price Targets
Multiple analysts have issued price targets for $DHR recently. We have seen 14 analysts offer price targets for $DHR in the last 6 months, with a median target of $230.0.
Here are some recent targets:
- Vijay Kumar from Evercore ISI Group set a target price of $230.0 on 07/06/2026
- David Westenberg from Piper Sandler set a target price of $200.0 on 06/11/2026
- Rajesh Kumar from HSBC set a target price of $230.0 on 06/03/2026
- Patrick Donnelly from Citigroup set a target price of $95.0 on 05/27/2026
- Dan Leonard from RBC Capital set a target price of $200.0 on 05/15/2026
- Kallum Titchmarsh from Morgan Stanley set a target price of $255.0 on 04/23/2026
- Subbu Nambi from Guggenheim set a target price of $235.0 on 04/22/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
